E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/2/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Medsurge wraps C$11.35 million private placement of shares

By Sheri Kasprzak

New York, Feb. 2 - Medsurge Medical Products Corp. has completed its previously announced private placement with a partly exercised greenshoe for C$11.35 million.

The company issued 4.54 million shares at C$2.50 each, including 540,000 shares that were issued as part of a partially exercised greenshoe.

Canaccord Capital Corp. was the placement agent for the deal.

The deal was priced Dec. 15 as a C$10 million offering of 4 million shares. Canaccord had been granted a greenshoe for up to 600,000 shares.

Proceeds will be used for working capital.

Based in Vancouver, B.C., Medsurge is a medical device company.

Issuer:MedSurge Medical Products Corp.
Issue:Stock
Amount:C$11.35 million
Shares:4.54 million (includes greenshoe for 540,000 shares)
Price:C$2.50
Warrants:No
Placement agent:Canaccord Capital Corp.
Pricing date:Dec. 15
Settlement date:Feb. 2
Stock symbol:TSX Venture: MSR
Stock price:C$3.59 at close Dec. 15
Stock price:C$4.72 at close Feb. 2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.